Your browser doesn't support javascript.
loading
Impact of capacity-limited binding on recombinant factor VIII and von Willebrand factor pharmacokinetics in hemophilia A rats.
Vargas Christensen, Isabell; Loftager, Mette; Rode, Frederik; Mørck Nielsen, Hanne; Kreilgaard, Mads; Larsen, Malte Selch.
Afiliação
  • Vargas Christensen I; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
  • Loftager M; Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
  • Rode F; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
  • Mørck Nielsen H; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
  • Kreilgaard M; Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
  • Larsen MS; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
J Thromb Haemost ; 17(6): 964-974, 2019 06.
Article em En | MEDLINE | ID: mdl-30924607

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Fator de von Willebrand / Hemofilia A Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Thromb Haemost Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Fator de von Willebrand / Hemofilia A Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Thromb Haemost Ano de publicação: 2019 Tipo de documento: Article